FILTER
FILTERED INTERVIEW RESULTS
Ryan Matthiesen
MANAGING DIRECTOR – INVESTMENT BANKING, HAYWOOD SECURITIES
Haywood Securities is a full service investment bank that is predominantly resources focused.
Jim Spenceley & Iain Humphreys
SENIOR VICE PRESIDENT-MINING & SANTIAGO OFFICE LEADER, BLACK & VEATCH
Understanding that holistic, integrated water management is critical for the future of mining in Chile, Black & Veatch provides the full spectrum of water management solutions, from desalination and seawater conveyance to water reuse and treatment.
Max Combes
COUNTRY MANAGER, GOLD FIELDS
Gold Field’s explains the progress at its Salares Norte project in Chile.
Kouamé Klemet-N’Guessan
PARTNER, KSK AVOCATS
KSK Avocats, a leading law firm in Côte d’Ivoire involved in the mining industry, explains the regulations related to operating in the country.
Dr. Ross Sherlock
PROFESSOR, DIRECTOR OF MERC AND METAL EARTH, CHAIR IN EXPLORATION TARGETING, LAURENTIAN UNIVERSITY
The Mineral Exploration Research Centre (MERC) is a part of the Harquail School of Earth Sciences (HES) at Laurentian University in Sudbury, Ontario.
Carla Martínez
GENERAL MANAGER, CANADA PERU CHAMBER OF COMMERCE (CCCP)
A discussion about the challenges and opportunities for Canadian investors in Peru’s mining industry.
Jose Vizquerra
CEO & DIRECTOR, O3 MINING INC.
O3 holds a unique portfolio of assets in Quebec and Ontario and which it is exploring.
Michael Gribbons
CO-FOUNDER AND VICE PRESIDENT – SALES & MARKETING, MAESTRO DIGITAL MINE
Maestro Digital Mine discusses its latest innovations, and which factors are generating demand.
Víctor Gobitz
CEO, BUENAVENTURA
Buenaventura outlines progress at its diverse portfolio of Peruvian assets.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
